News Article
CDC Study: PrEP Not Reaching Most Who Could Benefit
Posted on March 07, 2018
Blog:
A new study from the Centers for Disease Control and Prevention (CDC), presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI), suggests that only a small percentage of Americans who could potentially benefit from pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention, have been prescribed it. In the first detailed analysis by […]